4//SEC Filing
van der Baan Bastiaan Jeroen 4
Accession 0001493152-22-019515
CIK 0001335105other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:14 AM ET
Size
5.7 KB
Accession
0001493152-22-019515
Insider Transaction Report
Form 4
van der Baan Bastiaan Jeroen
Director
Transactions
- Award
Options to Purchase Common Stock
2022-06-17+250,000→ 250,000 totalExercise: $0.74From: 2022-06-17Exp: 2027-06-17→ Common (250,000 underlying)
Footnotes (1)
- [F1]In connection with the Reporting Person's appointment as a director of the Issuer, the Issuer granted to the Reporting Person options to purchase 250,000 shares of the Issuer's Common Stock exercisable for a period of five years at an exercise price of $0.74 vesting 50% on the date of the grant and the remaining 50% vesting 12.5% beginning in the quarter immediately subsequent to the date of the grant until fully vested, subject to continued service.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001938070
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 6:14 AM ET
- Size
- 5.7 KB